Vitalhub Corp. (VHI.TO) – What Are Investment Firms Saying About This Stock?

Shares of Vitalhub Corp. (TSE:VHI) have been given an average rating of “Buy” by the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is C$13.00.

Separately, Canaccord Genuity Group set a C$15.00 price target on shares of Vitalhub and gave the stock a “buy” rating in a report on Friday, August 28th.

Vitalhub Trading Up 0.4%

Shares of TSE:VHI opened at C$7.20 on Friday. The company has a 50 day moving average of C$7.68 and a 200 day moving average of C$7.43. The stock has a market cap of C$456.04 million, a P/E ratio of 60.00, a P/E/G ratio of 1.18 and a beta of 1.40. Vitalhub has a 12 month low of C$6.46 and a 12 month high of C$11.80.

Vitalhub (TSE:VHI) last posted its earnings results on Thursday, August 6th. The company reported C$0.03 earnings per share (EPS) for the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. The business had revenue of C$31.74 million for the quarter. On average, equities analysts forecast that Vitalhub will post 0.23 earnings per share for the current fiscal year.

Vitalhub Company Profile

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.